Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Lipid-complexed cisplatin

EU orphan designation number: EU/3/13/1169   
Active ingredient: Lipid-complexed cisplatin
Indication: Treatment of osteosarcoma
Sponsor: Richardson Associates Regulatory Affairs Ltd
Tripps Farmhouse, Lower End, Great Milton, Oxfordshire OX44 7NJ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/08/2013 Orphan designation EMA/OD/020/13 (2013)5269 of 05/08/2013